The development of urwhatueat started back in the beginning of 2001 by a local medical start-up here in Colorado Springs, Colorado named DiabetesManager/DMCare headed by CEO Steve Hyde. The application was developed by a team of web developers, certified diabetes educators, nurses, dieticians, and physicians. Some of that team included Jay Ferguson (Senior Web Developer), Judy Rodriguez (RD, CDE), Shelley Christian (RN, CDE), Polly Wilson (RN, MSN, CDE), and Robert Monoson (M.D., Chief Medical Officer)
The application took about eight months of design and develop. It was then linked off the website diabetesmanager.com for beta testing by the diabetesmanager patients. Our estimated launch date for the application was October 2001. Shorty after September 11, 2001 our company's largest investor pulled our funding and the company went under.
At that time we took the urwhatueat website offline, along with all of our other sites. Shortly after it going offline I started to receive emails from patients and other users of urwhatueat asking if we could put it somewhere they could use. We took a couple weeks to modernize the look and feel and update the general navigation and it has been live ever since. That is how urwhatueat came to be and it is now one of our most used websites and I am constantly getting great feedback from our users.
DIABETIC INSULIN PUMP MAKER INVESTS IN INTERNET SITE TO HELP DIABETICS MANAGE THEIR DISEASE - February 22, 2001.
MiniMed's Executive Chairman, Alfred E. Mann, stated, "We are happy to announce our investment in DMCare, which will help us offer our patients additional tools to better manage their disease. In order to best control diabetes, insulin-using patients must contend with the organization and analysis of a tremendous volume of information. The DMCare system will help our diabetes patients use the speed, access and convenience of the Internet to empower themselves to better control their disease on a daily basis."
NORTHRIDGE, Calif.--(BUSINESS WIRE)--Feb. 22, 2001
MiniMed Inc. (Nasdaq: MNMD) announced today that it has made an investment in DMCare, Inc. and entered into a strategic development agreement with the Colorado Springs based privately held company.
DMCare has developed and offers a novel on-demand intervention and educational web-based service to assist diabetes patients and their healthcare providers to optimize blood glucose control. DMCare currently offers automated dosing support services (within physician set guidelines) for diabetes patients who take insulin injections, as well as a wide range of patient-specific treatment, educational and online nurse counseling services. Under the terms of the agreement, DMCare will develop an automated dosing support algorithm that can be accessed and utilized exclusively by MiniMed insulin pump patients and their prescribing physicians. This partnership is consistent with MiniMed's strategy to attract a broader range of general practitioners to the Company's technologies and services.
In addition to the investment by MiniMed, the companies will participate in a number of cooperative initiatives, which include an automated insulin dosing support platform for pump patients, cross-marketing programs, reimbursement and data management initiatives, and patient and physician educational activities. All of these initiatives will be designed to streamline and reduce the common barriers associated with patient and physician adoption of intensive diabetes management.
MiniMed's Executive Chairman, Alfred E. Mann, stated, "We are happy to announce our investment in DMCare, which will help us offer our patients additional tools to better manage their disease. In order to best control diabetes, insulin-using patients must contend with the organization and analysis of a tremendous volume of information. The DMCare system will help our diabetes patients use the speed, access and convenience of the Internet to empower themselves to better control their disease on a daily basis."
Terry Gregg, MiniMed's President and Chief Operating Officer, added, "We are pleased to announce our alliance with DMCare, with whom we share a commitment to serving the diabetes patient community with the most advanced tools available to control their disease. This alliance will help us leverage the software capabilities of MiniMed's products, expand our presence into the broader primary care market, and provide additional support for our future diabetes product portfolio."
Stephen S. S. Hyde, DMCare's Chairman and CEO, said, "MiniMed represents the cutting edge of technology for improving the lives of the millions of people with diabetes who require insulin. We are gratified to have been chosen by MiniMed to partner in this next-generation service. Working together to provide the advantages of MiniMed's insulin infusion pumps and glucose sensors to a wider audience of physicians and their patients is our common goal. It is exciting to be associated with an organization that so fervently shares our dedication to improving the lives of people with diabetes."
MiniMed Inc. designs, develops, manufactures and markets advanced infusion systems with a primary emphasis on the intensive management of diabetes. The Company's products include external pumps and related disposables, a first generation continuous glucose monitoring system as well as exclusive marketing rights to an implantable insulin pump, which is currently approved for distribution in the European Community and has not yet been cleared for marketing in the U.S. The Company is also developing new infusion systems to deliver compounds designed to treat a variety of medical conditions.
The Manufacturer NewsWire - Apr 1, 2001 12:00 PM
MiniMed Finalizes Deal With DMCare: Northridge, Calif.-based MiniMed has signed a strategic agreement with Colorado Springs, Colo.-based DMCare that will give the companies access to each other's marketing and developmental strengths. Under terms of the agreement, DMCare will create a version of its Internet treatment for diabetes to coordinate the care of people who have insulin infusion pumps or use MiniMed's continuous glucose monitoring system. In addition, MiniMed has acquired an initial equity stake in DMCare.
